Equities

Coegin Pharma AB

COEGIN:NGM

Coegin Pharma AB

Actions
  • Price (SEK)0.166
  • Today's Change-0.001 / -0.60%
  • Shares traded843.52k
  • 1 Year change-55.50%
  • Beta--
Data delayed at least 15 minutes, as of Dec 05 2022.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Events & Activity

  • COEGIN:NGM price moved over -6.55% to 0.157
  • COEGIN:NGM price falls below 15-day moving average to 0.162 at 09:18 GMT
  • COEGIN:NGM price falls below 15-day moving average to 0.164 at 09:03 GMT
  • COEGIN:NGM price falls below 15-day moving average to 0.161 at 09:23 GMT
  • COEGIN:NGM price falls below 15-day moving average to 0.157 at 09:42 GMT

Key statistics

As of last trade, Coegin Pharma AB (COEGIN:NGM) traded at 0.166, 14.48% above the 52 week low of 0.145 set on Oct 18, 2022.
52-week range
Today
0.145Oct 18 20220.407Apr 01 2022
Open0.166
High0.17
Low0.161
Bid0.165
Offer0.166
Previous close0.167
Average volume933.70k
Shares outstanding694.29m
Free float559.13m
P/E (TTM)--
Market cap115.25m SEK
EPS (TTM)-0.0538
SEK
Data delayed at least 15 minutes, as of Dec 05 2022.
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.